These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 28011673

  • 1. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH, Brody J, Kohrt HE, Kolstad A, Czerwinski DK, Wälchli S, Green MR, Trøen G, Liestøl K, Beiske K, Houot R, Delabie J, Alizadeh AA, Irish JM, Levy R.
    Blood; 2017 Feb 09; 129(6):759-770. PubMed ID: 28011673
    [Abstract] [Full Text] [Related]

  • 2. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
    Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A.
    BMC Cancer; 2012 Oct 16; 12():478. PubMed ID: 23072591
    [Abstract] [Full Text] [Related]

  • 3. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V, Mraz M.
    Eur J Haematol; 2015 Mar 16; 94(3):193-205. PubMed ID: 25080849
    [Abstract] [Full Text] [Related]

  • 4. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
    Moyo TK, Wilson CS, Moore DJ, Eischen CM.
    Oncogene; 2017 Aug 10; 36(32):4653-4661. PubMed ID: 28368423
    [Abstract] [Full Text] [Related]

  • 5. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM.
    Nature; 2010 Jan 07; 463(7277):88-92. PubMed ID: 20054396
    [Abstract] [Full Text] [Related]

  • 6. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
    Bogusz AM, Baxter RH, Currie T, Sinha P, Sohani AR, Kutok JL, Rodig SJ.
    Clin Cancer Res; 2012 Nov 15; 18(22):6122-35. PubMed ID: 22966017
    [Abstract] [Full Text] [Related]

  • 7. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
    Palomba ML, Piersanti K, Ziegler CG, Decker H, Cotari JW, Bantilan K, Rijo I, Gardner JR, Heaney M, Bemis D, Balderas R, Malek SN, Seymour E, Zelenetz AD, van den Brink MR, Altan-Bonnet G.
    PLoS One; 2014 Nov 15; 9(1):e79987. PubMed ID: 24489640
    [Abstract] [Full Text] [Related]

  • 8. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
    Rip J, de Bruijn MJW, Neys SFH, Singh SP, Willar J, van Hulst JAC, Hendriks RW, Corneth OBJ.
    Eur J Immunol; 2021 Sep 15; 51(9):2251-2265. PubMed ID: 34323286
    [Abstract] [Full Text] [Related]

  • 9. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG.
    Blood; 2005 Jun 15; 105(12):4820-7. PubMed ID: 15728130
    [Abstract] [Full Text] [Related]

  • 10. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
    Kawauchi K, Ogasawara T, Yasuyama M.
    Int J Hematol; 2002 Jun 15; 75(5):508-13. PubMed ID: 12095152
    [Abstract] [Full Text] [Related]

  • 11. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
    Szydlowski M, Kiliszek P, Sewastianik T, Jablonska E, Bialopiotrowicz E, Gorniak P, Polak A, Markowicz S, Nowak E, Grygorowicz MA, Prochorec-Sobieszek M, Szumera-Cieckiewicz A, Malenda A, Lech-Maranda E, Warzocha K, Juszczynski P.
    Blood; 2016 Feb 11; 127(6):739-48. PubMed ID: 26585955
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.
    Bernard S, Danglade D, Gardano L, Laguillier C, Lazarian G, Roger C, Thieblemont C, Marzec J, Gribben J, Cymbalista F, Varin-Blank N, Ledoux D, Baran-Marszak F.
    Int J Cancer; 2015 Jun 15; 136(12):2761-74. PubMed ID: 25388373
    [Abstract] [Full Text] [Related]

  • 13. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
    Craxton A, Jiang A, Kurosaki T, Clark EA.
    J Biol Chem; 1999 Oct 22; 274(43):30644-50. PubMed ID: 10521450
    [Abstract] [Full Text] [Related]

  • 14. MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway.
    Wang WG, Jiang XN, Liu ZB, Zhou XY, Li XQ.
    Am J Surg Pathol; 2017 Apr 22; 41(4):541-549. PubMed ID: 28291124
    [Abstract] [Full Text] [Related]

  • 15. Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase.
    Jiang A, Craxton A, Kurosaki T, Clark EA.
    J Exp Med; 1998 Oct 05; 188(7):1297-306. PubMed ID: 9763609
    [Abstract] [Full Text] [Related]

  • 16. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
    Sohn HW, Gu H, Pierce SK.
    J Exp Med; 2003 Jun 02; 197(11):1511-24. PubMed ID: 12771181
    [Abstract] [Full Text] [Related]

  • 17. TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
    Whillock AL, Ybarra TK, Bishop GA.
    J Biol Chem; 2021 Jun 02; 296():100465. PubMed ID: 33639170
    [Abstract] [Full Text] [Related]

  • 18. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.
    Herman SE, Gordon AL, Hertlein E, Ramanunni A, Zhang X, Jaglowski S, Flynn J, Jones J, Blum KA, Buggy JJ, Hamdy A, Johnson AJ, Byrd JC.
    Blood; 2011 Jun 09; 117(23):6287-96. PubMed ID: 21422473
    [Abstract] [Full Text] [Related]

  • 19. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling.
    Pighi C, Gu TL, Dalai I, Barbi S, Parolini C, Bertolaso A, Pedron S, Parisi A, Ren J, Cecconi D, Chilosi M, Menestrina F, Zamò A.
    Cell Oncol (Dordr); 2011 Apr 09; 34(2):141-53. PubMed ID: 21394647
    [Abstract] [Full Text] [Related]

  • 20. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
    Le Roy C, Deglesne PA, Chevallier N, Beitar T, Eclache V, Quettier M, Boubaya M, Letestu R, Lévy V, Ajchenbaum-Cymbalista F, Varin-Blank N.
    Blood; 2012 Jul 12; 120(2):356-65. PubMed ID: 22613791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.